A case of aortic thrombus during chemotherapy for esophageal cancer

TAHARA Yuichi, HASHIMOTO Akira, OWA Hirono, ONO Takahiro, KURODA Naoki, AOKI Masatoshi, FUKE Hiroyuki, KAWABATA Hiroyuki, WAKITA Yoshihiro, SHIMIZU Atsuya

doi:10.11405/nisshoshi.121.212

<p>A 59-year-old man presented to our hospital with a chief complaint of epigastric pain. Pertinent history included a distal gastrectomy for gastric cancer and alcohol dependence. He underwent contrast-enhanced computed tomography (CT) and esophagogastroduodenoscopy, which led to a diagnosis of esophageal cancer (cT2N2M1, stage IVb). Subsequently, he underwent chemotherapy using 5-fluorouracil and cis-diamminedichloroplatinum and radiotherapy. A total of 44 days after treatment initiation, the patient experienced nausea and hepatobiliary enzyme elevation. CT and abdominal ultrasonography were performed, and he was diagnosed with an abdominal aortic thrombus. Intravenous heparin was administered as an anticoagulant therapy. Twenty-two days after treatment initiation, the thrombus was no longer visible on abdominal ultrasonography. The patient was then treated with warfarin. It cannot be ruled out that the patient's hepatobiliary enzyme elevation was induced by the anticancer drugs. However, enzyme elevation improved with the disappearance of the abdominal aortic thrombus, suggesting that the aortic thrombus may have contributed to the hepatobiliary enzyme elevation. No thrombus recurrence was observed until the patient's death after an initial treatment with antithrombotic agents. This case indicates that malignant tumors and chemotherapy can cause aortic thrombi, and thus, care should be exercised in monitoring this potential complication.</p>

A case of aortic thrombus during chemotherapy for esophageal cancer

Bibliographic Information

Abstract

Journal

Keywords

Details 詳細情報について

Export

Report a problem